Schmid, C.N.; Sponagel, K.; Bacher, U.; Seipel, K.; Porret, N.; Wiedemann, G.; Hoffmann, M.; Daskalakis, M.; Pabst, T.
Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma. Int. J. Mol. Sci. 2025, 26, 8021.
https://doi.org/10.3390/ijms26168021
AMA Style
Schmid CN, Sponagel K, Bacher U, Seipel K, Porret N, Wiedemann G, Hoffmann M, Daskalakis M, Pabst T.
Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma. International Journal of Molecular Sciences. 2025; 26(16):8021.
https://doi.org/10.3390/ijms26168021
Chicago/Turabian Style
Schmid, Corinne Natalie, Katharina Sponagel, Ulrike Bacher, Katja Seipel, Naomi Porret, Gertrud Wiedemann, Michèle Hoffmann, Michael Daskalakis, and Thomas Pabst.
2025. "Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma" International Journal of Molecular Sciences 26, no. 16: 8021.
https://doi.org/10.3390/ijms26168021
APA Style
Schmid, C. N., Sponagel, K., Bacher, U., Seipel, K., Porret, N., Wiedemann, G., Hoffmann, M., Daskalakis, M., & Pabst, T.
(2025). Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma. International Journal of Molecular Sciences, 26(16), 8021.
https://doi.org/10.3390/ijms26168021